It’s safe to say that July 1 was a better than average day for Suresh S. Ramalingam.
By coincidence, on that day he became the executive director of Winship Cancer Institute of Emory University and editor-in-chief of Cancer, a high-impact journal published by the American Cancer Society.
At Emory, Ramalingam, the center’s deputy director and the PI of the lung cancer SPORE succeeds Walter J. Curran Jr., who stepped down as executive director at Emory to become the global chief medical officer of GenesisCare (The Cancer Letter, Oct. 23, 2020).
